Vasa Therapeutics is a private biotechnology company focused on discovering and developing therapeutics that target the pathophysiology of cardiovascular aging. Based in San Diego with a presence in California and Poland, the company emphasizes novel approaches to treat heart failure, peripheral artery disease, sarcopenia, and related aging-related conditions. Their platform leverages computational chemistry and design to identify small molecules or peptides, advancing candidates through internal pipelines and external CRO collaborations. The leadership team has a track record of clinical and commercial success across therapeutic areas and modalities.
No recent news for this company.
No recent deals for this company.